Company / Debt per Share
Gossamer Bio, Inc. Debt per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
-
FY2024
5-year range
$0.00 / $0.39
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#80 of 82
Health Care
What the data says
Improved from $0.14 to $0.00 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 82
▼
Key checks
Key Insights
- Gossamer Bio, Inc.'s debt per share has declined for 5 consecutive years.
- In FY2024, debt per share decreased 100.0% year-over-year.
- Peak debt per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.01 | -96.2% |
| FY2022 | $0.14 | -63.5% |
| FY2021 | $0.39 | -7.4% |
| FY2020 | $0.42 | -19.3% |
| FY2019 | $0.52 | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026